New Drugs and Clinical Trials Rules, 2019
FlashcardsQuick reviseKey facts. One by one.Start →Also called: NDCT Rules · Topic: Consumer Rights and Consumer Protection · NCERT: Beyond NCERT
Meaning
The New Drugs and Clinical Trials Rules, 2019 (NDCT Rules) are India's rules for approving new medicines. A new drug is one not yet approved for use in India. A clinical trial is a planned test of a drug on human volunteers. The rules come under the Drugs and Cosmetics Act, 1940, and the regulator CDSCO (Central Drugs Standard Control Organisation) applies them. A company has to show trial evidence that a drug is safe and that it works before it gets permission to sell it. So the job of proving the drug is on the seller, not on the patient. This protects the consumer's right to safety in a market where the seller knows far more about the product than the buyer. Economists call that gap information asymmetry.
Example
An Indian firm wants to launch a new peptide injection for faster healing. Under the NDCT Rules, it must first get permission to run trials, then test the drug on humans, then show the results to CDSCO. Only then can it sell the drug. Selling it online for "recovery" or "wellness" without this approval puts it outside the legal route.
Don't confuse with
- Drugs and Cosmetics Act, 1940: this is the parent law, passed by Parliament. The NDCT Rules are made under it and set out the detailed approval steps for new drugs and trials.
- Drugs, Medical Devices and Cosmetics Bill, 2022: this is a proposed law that would replace the 1940 Act. It has not been passed, so it is not yet in force.